Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 8:12:1853-1862.
doi: 10.2147/IJN.S131235. eCollection 2017.

Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment

Bo Wu  1 , Shu-Ting Lu  2 , Liu-Jie Zhang  3 , Ren-Xi Zhuo  3 , Hai-Bo Xu  2 , Shi-Wen Huang  3
Affiliations

Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment

Bo Wu et al. Int J Nanomedicine. .

Abstract

Codelivery is a promising strategy to overcome the limitations of single chemotherapeutic agents in cancer treatment. Despite progress, codelivery of two or more different functional drugs to increase anticancer efficiency still remains a challenge. Here, reduction-sensitive lipid-polymer hybrid nanoparticles (LPNPs) drug delivery system composed of monomethoxy-poly(ethylene glycol)-S-S-hexadecyl (mPEG-S-S-C16), soybean lecithin, and poly(D,L-lactide-co-glycolide) (PLGA) was used for codelivery of doxorubicin (DOX) and a Chinese herb extract triptolide (TPL). Hydrophobic DOX and TPL could be successfully loaded in LPNPs by self-assembly. More importantly, drug release and cellular uptake experiments demonstrated that the two drugs were reduction sensitive, released simultaneously from LPNPs, and taken up effectively by the tumor cells. DOX/TPL-coloaded LPNPs (DOX/TPL-LPNPs) exhibited a high level of synergistic activation with low combination index (CI) in vitro and in vivo. Moreover, the highest synergistic therapeutic effect was achieved at the ratio of 1:0.2 DOX/TPL. Further experiments showed that TPL enhanced the uptake of DOX by human oral cavity squamous cell carcinoma cells (KB cells). Overall, DOX/TPL-coencapsulated reduction-sensitive nanoparticles will be a promising strategy for cancer treatment.

Keywords: codelivery; reduction sensitive; synergistic effect; triptolide.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
The schematic drawing of dual drug-loaded LPNPs. Abbreviations: DOX, doxorubicin; LPNPs, lipid–polymer hybrid nanoparticles; mPEG-S-S-C16, monomethoxy-poly(ethylene glycol)-S-S-hexadecyl; PLGA, poly(d,l-lactide-co-glycolide); TPL, triptolide.
Figure 2
Figure 2
(A) Cytotoxicity of DOX-based combinations (DOX/TPL-1/0.05, 1/0.1, 1/0.2, 1/0.5, and 1/1) against KB cells after incubation for 48 h (n=4). (B) Plot of the combination index as the function of cell viability for KB cells treated with free DOX and free TPL combinations. Abbreviations: DOX, doxorubicin; TPL, triptolide.
Figure 3
Figure 3
CI values at ED50 of DOX-based combinations (DOX dosage was 200 ng/mL). Abbreviations: CI, combination index; ED50, 50% effective dose; DOX, doxorubicin; TPL, triptolide.
Figure 4
Figure 4
TEM image of DOX/TPL-loaded LPNPs. Abbreviations: DOX, doxorubicin; LPNPs, lipid–polymer hybrid nanoparticles; TEM, transmission electron microscopy; TPL, triptolide.
Figure 5
Figure 5
Redox-triggered release of (A) DOX and (B) TPL from DOX/TPL-1/0.2-loaded LPNPs in PBS (0.01 M, pH 7.4) with or without 10 mM DTT. Note: P-values were calculated by the Student’s t-test: **P<0.005. Abbreviations: DOX, doxorubicin; DTT, dithiothreitol; LPNPs, lipid–polymer hybrid nanoparticles; PBS, phosphate-buffered saline; TPL, triptolide.
Figure 6
Figure 6
(A) Cytotoxicity of drug-loaded LPNPs against KB cells after incubation for 48 h (n=4). (B) Plot of the CI as the function of cell viability for KB cells treated with drug-loaded LPNPs. P-values were calculated by the Student’s t-test: *P<0.05. Abbreviations: CI, combination index; DOX, doxorubicin; LPNPs, lipid–polymer hybrid nanoparticles; TPL, triptolide.
Figure 7
Figure 7
Antitumor effect of free drugs and drug-loaded LPNPs on H22 cell xenografts tumor. Note: P-values were calculated by the Student’s t-test: *P<0.05 and **P<0.005. Abbreviations: DOX, doxorubicin; LPNPs, lipid–polymer hybrid nanoparticles; PBS, phosphate-buffered saline; TPL, triptolide.
Figure 8
Figure 8
Flow cytometry analyses of KB cells incubated with (A) free drugs and (B) drug-loaded LPNPs for 6 h. Note: DOX dosage was 200 ng/mL, and TPL dosage was 40 ng/mL. Abbreviations: DOX, doxorubicin; LPNPs, lipid–polymer hybrid nanoparticles; TPL, triptolide.
Figure 9
Figure 9
Confocal laser scanning microscopy images of KB cells after treatment with (A) TPL-loaded LPNPs, (B) DOX-loaded LPNPs, and (C) DOX/TPL-1/0.2-loaded LPNPs for 6 h. Notes: DOX dosage was 200 ng/mL, and TPL dosage was 40 ng/mL. Magnification 60×. Abbreviations: DOX, doxorubicin; LPNPs, lipid–polymer hybrid nanoparticles; TPL, triptolide.
See this image and copyright information in PMC

References

    1. Cai L, Xu G, Shi C, Guo D, Wang X, Luo J. Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: a synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials. 2015;37:456–468. - PMC - PubMed
    1. Gadde S. Multi-drug delivery nanocarriers for combination therapy. Med Chem Commun. 2015;6(11):1916–1929.
    1. Lehar J, Krueger AS, Avery W, et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol. 2009;27(7):659–666. - PMC - PubMed
    1. Shastri L, Abdelhamid HN, Nawaz M, et al. Synthesis, characterization and bifunctional applications of bidentate silver nanoparticle assisted single drop microextraction as a highly sensitive preconcentrating probe for protein analysis. RSC Adv. 2015;5(52):41595–41603.
    1. Chen D, Wang G, Song W, et al. Novel CD44 receptor targeting multifunctional “nano-eggs” based on double pH-sensitive nanoparticles for co-delivery of curcumin and paclitaxel to cancer cells and cancer stem cells. J Nanopart Res. 2015;17(10):1–10.

MeSH terms

LinkOut - more resources